Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street

Pharma stocks jumped up to 20% on Monday, led by strong buying momentum across the sector, despite a weak sentiment in the broader Indian stock market. The rally in pharma stocks lifted the Nifty Pharma index by 1.65%.

Torrent Pharmaceuticals and Mankind Pharma were the top gainers on the Nifty Pharma index with more than 3% rally each. Cipla, Divi’s Laboratories, Laurus Labs, Alkem Laboratories and Sai Life Sciences shares rose over 2% each, while Zydus Lifesciences, Aurobindo Pharma and Ajanta Pharma shares witnessed gains of over 1%.

Among other pharma stocks, RPG Life Sciences, Thyrocare Technologies, Hester Biosciences, Onesource Specialty Pharma and Neuland Laboratories shares surged up to 7%.

Additionally, Tatva Chintan Pharma Chem share price jumped 20% to hit a fresh 52-week high of ₹1,714.10 apiece on the BSE, after strong Q1 results.

The rally in pharma stocks today came despite a weak trend in the broader Indian stock market today, following a decline in global markets as the escalating US-Iran war and surging crude oil prices kept investor sentiment cautious.

The BSE Sensex was trading 671.29 points, or 0.86%, lower at 77,480.16, while the NSE Nifty 50 was down by 169.40 points, or 0.70%, at 24,164.75.

Ankit Gohel is the Deputy Chief Content Producer at Livemint, specialising in financial markets, macroeconomics, and regulatory developments. With a strong focus on equity markets, primary issuances, and policy-driven market movements, he brings clarity to complex financial developments for investors and market participants. <br><br> With nine years of experience in business and financial journalism, Ankit’s approach is rooted in the belief that market reporting should go beyond headlines — connecting data, policy, and ground realities to deliver actionable insights. His work consistently bridges the gap between institutional analysis and investor understanding. <br><br> Ankit has spent three years at Livemint, where he currently helps drive market coverage, editorial strategy, and high-impact financial stories. Prior to this, he worked with leading business news networks such as CNBC-TV18, ET Now, TickerPlant News Service where he built deep expertise in stock market analysis, macroeconomic trends, primary markets, and coverage of key regulators including the RBI and SEBI. <br><br> Over the years, he has covered market cycles across bull and bear phases, IPO booms, liquidity shocks, and major policy shifts that reshaped investor sentiment. He has interviewed fund managers, corporate leaders, and policymakers, translating their perspectives into sharp, data-backed narratives. Ankit combines speed with accuracy — ensuring timely, credible, and insight-driven financial journalism that empowers both retail and institutional audiences.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Log in to our website to save your bookmarks. It'll just take a moment.

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.